- ‘Welcome to the edge of freedom’: Biden’s boots touch down in DMZ
- Obama: Hole U.S. ‘digging out of’ requires billions more in unemployment benefits
- Obama’s regulatory agenda will cost U.S. economy $143B next year: report
- Patriot Act author on James Clapper: Fire, prosecute him
- Russia P.M. Medvedev: No amnesty for political prisoners
- Michigan GOP Senate hopeful reminds government is the ‘servant’
- Christmas, by Congress: Members mull a 15-cent tax on trees
- U.S. unemployment falls to five-year low of 7 percent; 203K jobs added
- World mourns Nelson Mandela and celebrates his life; burial set for Dec. 15
- Bill O’Reilly reminds: Nelson Mandela ‘was a communist’
Stock rally evaporates after Bernanke testimony
On Friday, after the government reported that the country created only 69,000 jobs in May, gold rocketed $58 an ounce, partly because investors believed the Fed might step in.
The sharp moves up and down aren’t likely to stop until there’s a clear answer from the Fed, said Jon Nadler, senior analyst at Kitco Metals. That may take until June 20, when the Fed holds its next policy meeting.
“This is a market built on anticipation and little else,” he said.
Michelle Girard, senior U.S. economist with Royal Bank of Scotland, said the Fed may extend a program called Operation Twist, in which it sells short-term securities and buys long-term bonds to drive down long-term interest rates, for a few months. That program is set to expire at the end of this month.
Investor fear has grown recently that Greece will leave the euro currency union, triggering a financial a panic in Europe and dragging down the rest of the world economy.
Some fear over Europe was allayed Thursday when Spain raised $2.6 billion from the bond market. The interest rate on its benchmark 10-year note fell to 6.02 percent from 6.26 percent late Wednesday in trading on the secondary market, a sign that bond investors have more confidence in Spain’s finances.
Among stocks making big moves in the U.S.:
• Pharmacyclics Inc. rose $1.96, or 6 percent, to $36.73 after an analyst predicted that the company’s experimental lymphoma drug could grow into a blockbuster product.
• Molina Healthcare, an insurance company, plunged $7.99, or 31 percent, to $17.77 after it withdrew its 2012 profit forecast, citing a possible revenue shortfall in Texas.
• Men’s Wearhouse dropped $6.72, or 19 percent, to $28.85 after reporting disappointing financial results and issuing a weak forecast for its second quarter.
- Bill OReilly reminds: Nelson Mandela was a communist
- Obama administration issues permits for wind farms to kill more eagles
- Spike in battlefield deaths linked to restrictive rules of engagement
- PRUDEN: British press horrified as London's new mayor dares to proclaim the truth
- Obama: Hole U.S. 'digging out of' requires billions more in unemployment benefits
- Rush Limbaugh: Obama trying to make Mandela death about himself
- Kill team: Obama war chiefs widen drone death zones
- NAPOLITANO: Pope Francis should be saving souls, not pocketbooks
- 'Dude, I'm dreading that I will have to go': Czech prime minister on Mandela funeral
- John Boehner says GOP should support gay candidates: I do
Independent voices from the The Washington Times Communities
Find the latest news and happening that effect those in the Washington D.C., Northern Virginia and Maryland Metro region.
A stat-head’s outlook, direct from his worn in couch cushion.
Classical music and the performing arts: news and reviews you can use.
Covering the world of soccer, including the World Cup, Major League Soccer, D.C. United and the English Premier League and other interesting sporting events.
White House pets gone wild!